GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: The Journal of Gene Medicine, Wiley, Vol. 11, No. 10 ( 2009-10), p. 889-898
    Abstract: Dendritic cell (DC)‐based vaccines have become a promising modality in cancer immunotherapy. However, their ability to initiate tumor antigen‐specific T cell immunity is limited in various negative‐feedback mechanisms. The rapid down‐regulation of chemokines, such as the interferon inducible protein of 10 kDa (IP‐10), which chemoattracts activated antigen‐specific CD8 + T cells, would represent negative‐feedback regulation. Therefore, we attempted to improve DC vaccine potency by introducing the IP‐10 gene retrovirally aiming to replenish the chemoattractive activity of DCs. Methods We introduced IP‐10 gene into DC2.4 cells, referred to as DC‐IP10, using a retroviral system. Nonsecretable mIP‐10‐expressing DCs (DC‐mIP10) were also prepared to evaluate the effects of secretion in IP‐10‐mediated modulation of DC biology. Additionally, in vitro and in vivo activation of antigen‐specific T lymphocytes and in vivo anti‐tumor effects induced by DC‐IP10 or DC‐mIP10 were determined. Results The modification of DC2.4 cells with the IP‐10 gene resulted in the secretion of functionally chemoattractive IP‐10 and, unexpectedly, a significant up‐regulation of surface expression in co‐stimulatory molecules, such as CD40 and CD80, compared to that of DCs with vector control (DC‐no insert). DC‐mIP10 also displayed the partially matured phenotypes but failed to recruit antigen‐specific T cells in an in vitro cell culture system. Consistently, DC‐IP10 generated more tumor antigen‐specific CD8 + T cells and stronger anti‐tumor effects in vaccinated mice than did control DCs and DC‐mIP10. Conclusions The results obtained provide the groundwork for a future clinical translation of the chemokine‐based genetic modification of DCs to increase their vaccine potency. Copyright © 2009 John Wiley & Sons, Ltd.
    Type of Medium: Online Resource
    ISSN: 1099-498X , 1521-2254
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2009
    detail.hit.zdb_id: 2002203-7
    detail.hit.zdb_id: 1458024-X
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...